Brain+

Brain+ is a pioneer in developing Digital Therapeutics / Digital Medicine to detect and treat the cognitive symptoms of dementia and Alzheimer's.

[Brain+ @TheBrainPlus]

BRAIN+ SHOWCASED AT DANISH DEMENTIA DAYS & ALTENPFLEGE IN GERMANY
- Brain+ was selected as one of the most promising new elderly care technology start-ups at the annual German elderly care conference, Altenpflege

https://t.co/LUwG02z1K7

[Brain+ @TheBrainPlus]

The Dementia Days 2023 conference in Copenhagen is concluded with over 1000 participants.

Thank you to all who stopped by our booth for a talk about CST and how we can support your work with the CST-Assistant.

[Brain+ @TheBrainPlus]

BRAIN+ CLOSES ITS SECOND SALES CONTRACT FOR CST
- Therapist Companion with a dementia care center in Gladsaxe municipality
https://t.co/MGlZgJ03zx

[Brain+ @TheBrainPlus]

Learn more about the current Brain+ unit rights issue:

Topics discussed:
- Turbulent market conditions
- Existing shareholders
- What you get in the rights issue
- Use of funds
- The business case of Brain+

https://t.co/7XK8F8kJvQ

[Brain+ @TheBrainPlus]

MALTESER HILFSDIENST AND BRAIN+ BEGIN COLLABORATION
to offer people with dementia access to CST in special dementia cafes in Germany

The first step is a 2-months pilot offering of Brain+’ German version of CST-Therapist Companion

https://t.co/j8N49PH0PB

[Brain+ @TheBrainPlus]

Germany sets a new digitalization strategy further supporting the adoption of digital therapeutics in Europe’s largest healthcare market.

Read more: https://t.co/zjfNJebUaO

#alzheimers #dementia #DTx #digitaltherapeutics #digitalmedicine #brainhealth #mentalhealth

[Brain+ @TheBrainPlus]

A key finding from the recently released 2nd systematic Cochrane review (Woods et al., 2023) is the confirmation that medication combined with CST results in significantly larger benefits over and above that of medication alone.

Read more: https://t.co/y1PRFFbmCG

#alzheimers

[Brain+ @TheBrainPlus]

BRAIN+ EXPANDS ITS FIRST SALES CONTRACT, close to doubling it

This is important because it shows the potential for growing engagements with customers after an initial contract has been established

https://t.co/zmMuYepNc7

[Brain+ @TheBrainPlus]

RESPECTED DEMENTIA EXPERTS AND BRAIN+ GET EU GRANT TO RESEARCH how to optimize digital at-home treatments for people with dementia
- The grant (€48,405) covers research into the two main therapeutic technologies of Brain+, digitalized CST, and CCT.
https://t.co/5sgDr5KSUC

[Brain+ @TheBrainPlus]

NEW COCHRANE REVIEW CONFIRMS CST
Provides further solid support for the increased adoption of CST as a non-pharmaceutical dementia therapy worldwide and for Brain+’ CST-based suite of digital dementia products.
https://t.co/Rp6BfmZUsf

[Brain+ @TheBrainPlus]

Important opportunity for Brain+ to present its innovative digital solutions for better care and treatment of Alzheimer’s and other types of dementia to key Japanese industry and academic stakeholders.

Read more: https://t.co/ycFwMluGto

#alzheimers #dementia #DTx

[Brain+ @TheBrainPlus]

The ‘Alzheimer’s Detect & Prevent’ project, led by Brain+ and funded under the EU Horizon2020 innovation framework, has been approved by the European Commission.

Read more: https://t.co/f0ZG0a73Qr

#alzheimers #dementia #DTx #digitaltherapeutics #digitalmedicine #brainhealth

[Brain+ @TheBrainPlus]

Brain+ completes Swedish research version of its dementia product with the Research Institutes of Sweden and extends the collaboration

https://t.co/y0X4NLuGIo

[Brain+ @TheBrainPlus]

Promising feasibility indications for Brain+’ CCT technology for cognitive training

Indications of clinical feasibility of the CCT technology & Starry Night cognitive test, provide early support for the pipeline product for Mild Cognitive Impairment.

https://t.co/XCMbIm1fyI

[Brain+ @TheBrainPlus]

Brain+ first municipal sale of its new dementia product

- The sale covers the use of the ‘basic package’ of the CST-Therapist Companion in one training facility for one year, in the municipality of Herning, at an introductory price of 50.000 DKK.

https://t.co/MZnBiczeG9

[Brain+ @TheBrainPlus]

3-Year Innovation Project is Completed
with the Brain+ CST-Therapist Companion product as the final output

The 3-year ‘CIRCULAR Co-Creation’ project has been the backbone of the development of all the Brain+ CST products.
https://t.co/ATfS9CGrxh

[Brain+ @TheBrainPlus]

Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful capital raise, and several supportive market news announcements.

https://t.co/b5S7NKsvb1

[Brain+ @TheBrainPlus]

Pilot with volunteers from DaneAge Association

Brain+ is excited to announce the launch of a pilot project with DaneAge (Ældre Sagen) to test the use of CST-Therapist Companion to enable volunteers to deliver CST to the members of the association.

https://t.co/khVyAvWR9A

[Brain+ @TheBrainPlus]

Implementation of an ISO 13485 for Medical Devices

Having a standardized QMS in place is key requirement for development & commercialization of compliant digital therapeutics. Supports the company’s objective to attract large pharma partnerships.

https://t.co/eGcc0A3GYX

[Brain+ @TheBrainPlus]

WHO endorses CST and digital solutions of dementia therapy
- Brain+ is at the forefront of digital therapeutics and the first to have developed a digital version of CST for its upscaled and wider use and adoption

https://t.co/T8tqaPQ6zs